RecruitingPhase 1NCT06575296
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Sponsor: City of Hope Medical Center
Duarte, CA
Leukemia clinical trials in Duarte, CA
43 recruiting leukemia studies with a site in Duarte, CA.
RecruitingPhase 1NCT06846606
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Sponsor: Auron Therapeutics, Inc.
Duarte, CA · +8 more sites
RecruitingPhase 1NCT06528301
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Sponsor: Umoja Biopharma
Duarte, CA · +6 more sites
RecruitingPhase 1 / Phase 2NCT07109219
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Sponsor: AstraZeneca
Duarte, CA · +5 more sites
RecruitingPhase 2NCT06128070
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 1 / Phase 2NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Sponsor: AstraZeneca
Duarte, CA · Los Angeles, CA · Palo Alto, CA · +9 more sites
RecruitingPhase 1 / Phase 2NCT04065399
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Sponsor: Syndax Pharmaceuticals
Duarte, CA · Los Angeles, CA · Palo Alto, CA · +19 more sites
RecruitingPhase 2NCT05672251
Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 1NCT07751991
A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
Sponsor: Charm Therapeutics
Duarte, CA · +2 more sites
RecruitingPhase 2NCT07061951
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
Sponsor: National Cancer Institute (NCI)
Duarte, CA · Irvine, CA · Sacramento, CA · +6 more sites
RecruitingPhase not listedNCT07613385
Individualized AML Treatment
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 2 / Phase 3NCT07581002
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Sponsor: AbbVie
Duarte, CA · +5 more sites
RecruitingPhase 1NCT03802695
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Sponsor: Orca Biosystems, Inc.
Duarte, CA · Sacramento, CA · Stanford, CA · +9 more sites
RecruitingPhase 2NCT06514794
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Sponsor: Allotera Therapeutics
Duarte, CA · Los Angeles, CA · +14 more sites
RecruitingPhase 3NCT07277231
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Sponsor: BeOne Medicines
Duarte, CA · Orange, CA · Palo Alto, CA · +19 more sites
RecruitingPhase 3NCT06852222
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Sponsor: Janssen Research & Development, LLC
Duarte, CA · +58 more sites
RecruitingPhase 3NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Sponsor: Syndax Pharmaceuticals
Duarte, CA · +5 more sites
RecruitingPhase 3NCT04293562
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Sponsor: Children's Oncology Group
Downey, CA · Duarte, CA · Loma Linda, CA · +183 more sites
RecruitingPhase 2NCT07221500
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Sponsor: Nurix Therapeutics, Inc.
Duarte, CA · Los Angeles, CA · San Diego, CA · +24 more sites
RecruitingPhase 1NCT06735664
Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 2NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Sponsor: Cogent Biosciences, Inc.
Duarte, CA · Los Angeles, CA · Stanford, CA · +11 more sites
RecruitingPhase 1NCT07025564
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 1NCT07250646
A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
Sponsor: Aspera Biomedicines, Inc.
Duarte, CA · Sacramento, CA · San Diego, CA
RecruitingPhase 1NCT05131022
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Sponsor: Nurix Therapeutics, Inc.
Duarte, CA · San Francisco, CA · +16 more sites
RecruitingPhase 1NCT06996119
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 1 / Phase 2NCT07356154
A Study of Revumenib and Mezigdomide in People With Leukemia
Sponsor: Memorial Sloan Kettering Cancer Center
Duarte, CA · +9 more sites
RecruitingPhase 1NCT03113643
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Sponsor: Dana-Farber Cancer Institute
Duarte, CA · +2 more sites
RecruitingPhase not listedNCT05865301
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
Sponsor: Stanford University
Duarte, CA · Palo Alto, CA · San Francisco, CA · +19 more sites
RecruitingPhase not listedNCT05978141
A Registry for People With T-cell Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Duarte, CA · San Diego, CA · San Francisco, CA · +23 more sites
RecruitingPhase 2NCT06588478
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor: Loxo Oncology, Inc.
Duarte, CA · Irvine, CA · Palo Alto, CA · +18 more sites
RecruitingPhase not listedNCT01790152
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Sponsor: Children's Oncology Group
Duarte, CA · Madera, CA · Oakland, CA · +66 more sites
RecruitingPhase 1NCT05101551
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Sponsor: Norman J. Lacayo
Duarte, CA · Stanford, CA · +7 more sites
RecruitingPhase 1NCT06859008
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 1 / Phase 2NCT04329728
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Sponsor: AVM Biotechnology Inc
Duarte, CA · Los Angeles, CA · +8 more sites
RecruitingPhase 2NCT07218510
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Sponsor: City of Hope Medical Center
Duarte, CA · Irvine, CA · Long Beach, CA · +4 more sites
RecruitingPhase 1NCT05672147
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 2NCT05194397
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Sponsor: Children's Hospital of Philadelphia
Duarte, CA · +2 more sites
RecruitingPhase 1NCT06501196
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Sponsor: BlossomHill Therapeutics
Duarte, CA · Los Angeles, CA · Palo Alto, CA · +10 more sites
RecruitingPhase 1NCT06462365
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Sponsor: Tr1X, Inc.
Duarte, CA · +4 more sites
Not yet recruitingPhase 2NCT07812246
Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial
Sponsor: City of Hope Medical Center
Duarte, CA · Irvine, CA · +1 more sites
Not yet recruitingPhase 1NCT07758673
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Sponsor: City of Hope Medical Center
Duarte, CA · Irvine, CA
Not yet recruitingPhase 1NCT07722767
A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients
Sponsor: Cullinan Therapeutics Inc.
Duarte, CA · +2 more sites
Not yet recruitingPhase 2NCT07582159
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor: City of Hope Medical Center
Duarte, CA · Irvine, CA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.